Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4

Glycobiology

Volumn 8, Issue 2, 1998, Pages 131-137

  Harrop, Hilary A ^a   Rider, Christopher C ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chemically modified heparin; Glycosaminoglycan; gp 120; Heparan sulfate; V3 loop

Indexed keywords

CD4 ANTIGEN; HEPARIN; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; TRITIUM; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RADIOASSAY; SCATCHARD PLOT;

ANIMALS; ANTIGENS, CD4; BINDING, COMPETITIVE; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPARIN; HEPARITIN SULFATE; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; HYDROCHLORIC ACID; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECOMBINANT PROTEINS; SWINE; TRITIUM; TROMETHAMINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; TRITIUM;

EID: 0031932210     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/8.2.131     Document Type: Article

References (33)

1. Anand, R., Nayyar, S., Galvin, T.A., Merril, C.R. and Bigelow, L.B. (1990) Sodium pentosan polysulfate (PPS), an anti-HIV agent also exhibits synergism with AZT, lymphoproliferative activity, and virus enhancement. AIDS Res. Hum. Retrov., 6, 679-689.
2. Aoki, T., Kaneko, Y., Nguyen, T., Stefanski, M.S., Ting, R.C.Y. and Manak, M.M. (1992) Curdlan sulfate and HTV-1. II. In vitro long-term treatment of HIV-1 infection with curdlan sulfate. AIDS Res. Hum. Retrov., 8, 605-612.
3. Baba, M, Snoeck, R., Pauwels, R. and Declercq, E. (1988a) Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus and human immunodeficiency virus. Antimicrob. Agents Chemother., 32, 1742-1745.
4. Baba, M., Nakajima, M., Schols, D., Pauwels, R., Balzarini, J. and De Clercq, E. (1988b) Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. Antiviral Res., 9, 335-343.
5. Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J. and De Clercq, E. (1988c) Mechanism of inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA, 85, 6132-6136.
6. Baba, M., Schols, D., Pauwels, R., Nakashima, H. and De Clercq, E. (1990) Sulfated polysaccharides as potent inhibitors of HIV-1 induced syncytium formation: a new strategy towards AIDS chemotherapy. J. Acquired Immune Defic. Syndr., 3, 493-499.
7. Bagasra, O. and Lischner, H.W. (1988) Activity of dextran sulfate and other polysaccharides against human immunodeficiency virus. Jnl. Infect. Dis., 158, 1084-1087
8. Batinic, D. and Robey, F.A. (1992) The V3 region of the envelope glycoprotein of human immunodeficicency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem., 267, 6664-6671.
9. Bhattacharyya, D., Brooks, B.R. and Callahan, L. (1996) Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype. AIDS Res. Hum. Retrov., 12, 83-90.
10. Callahan, L.N., Phelan, M., Mallinson, M. and Norcross, M.A. (1991) Dextran sulfate blocks antibody binding to the principle neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J. Virol., 65, 1543-1550.
11. Catasti, P., Fontenot, J.D., Bradbury, E.M. and Gupta, G. (1995) Local and global structures of the HIV-MN V3 loop. J. Biol. Chem., 270, 2224-2232.
12. Cocchi, F., DeVico, A.L., Garzino-Demo, A., Cara, A., Gallo, R.C. and Lusso, P. (1996) The V3 domain of HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nature Med., 2, 1244-1247.
13. Coombe, D.R., Harrop, H.A., Watton, J., Mulloy, B., Barrowcliffe, T.W. and Rider, C.C. (1995) Low anticoagulant heparin retains anti-HIV type 1 activity in vitro. AIDS Res. Hum. Retrov., 11, 1393-1396.
14. Gallagher, J.T., Turnbull, J.E. and Lyon, M. (1992) Patterns of sulfation in heparan sulfate - polymorphism based in a common structural theme. Int. J. Biochem., 24, 553-560.
15. Harrop, H.A., Coombe, D.R. and Rider, C.C. (1994) Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding. AIDS, 8, 183-292.
16. Hwang, S.S., Boyle, T.J., Lyerly, H.K. and Cullen, B.R. (1991) Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science, 253, 71-74.
17. Johnson, E.A. (1984) Heparan sulfates from porcine intestinal mucosa. Preparation and physiochemical properties. Thrombosis Res., 35, 583-588.
18. LaRosa, G.J., Davide, J.P., Weinhold, K., Waterbury, J.A., Profy, A.T., Lewis, J.A., Langlois, A.J., Dressman, G.R., Boswell, R.N., Shadduck, P., Holley, L.H., Karplus, M., Bolognesi, D.P., Mathews, T.J., Emini, E.A. and Putney, S.D. (1990) Conserved sequence and structural elements in the HIV-1 principle neutralizing determinant. Science, 249, 932-935.
19. Lee, M.K., and Lander, A.D. (1991) Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach. Proc. Natl. Acad. Sci. USA, 88, 2768-2772.
20. Lederman, S., Gulick, R. and Chess, L. (1989) Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. J. Immunol., 143, 1149-1154.
21. Maccarana, M. and Lindahl, U. (1993) Mode of interaction between platelet factor 4 and heparin. Glycobiology, 3, 271-277.
22. McClure, M.O., Moore, J.P., Blanc, D.F., Scotting, P., Cook, G.M.W., Keynes, R.J., Weber, J.N., Davies, D. and Weiss, R.A. (1992) Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res. Hum. Retrov., 8, 19-26.
23. Mulloy, B., Forster, M.J., Jones, C., Drake, A.F., Johnson, E.A. and Davies, D.B. (1994) The effect of variation of substitution on the solution conformation of heparin - a spectroscopic and molecular modeling study. Carbohydr. Res., 255, 1-26.
24. Nara, P.L., Garrity, R.R. and Goudsmit, J. (1991) Neutralization of HIV-1: a paradox of humoral proportions. FASEB J., 5, 2437-2455.
25. Parish, C.R., Low, L., Warren, H.S. and Cunnigham, A.L. (1990) A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding site. J. Immunol., 145, 1188-1195.
26. Patel, M., Yanagishita, M., Roderiquez, G., Bouhabib, D.C., Oravecz, T., Hascall, V.C. and Norcross, M.A. (1993) Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Human Retrovir., 9, 167-174.
27. Rider, C.C., Coombe, D.R., Harrop, H.A., Hounsell, E.F. Bauer, C., Feeney, J., Mulloy, B., Mahmood, N., Hay, A. and Parish, C.R. (1994) Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitro. Biochemistry, 33, 6974-6980.
28. Roderiquez, G., Oravecz, T., Yanagishita, M., Chequer, D., Bou-Habib, D.C., Mostowski, H. and Norcross, M.A. (1995) Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol., 69, 2233-2239.
29. Sheih, M.-T. and Spear, P.G. (1994) Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J. Virol., 68, 1224-1228.
30. Stringer, S.E. and Gallagher, J.T. (1997) Specific binding of the chemokine platelet factor 4 to heparan sulphate. J. Biol. Chem., 272, 20508-20514.
31. Ueno, R., and Kuno, S. (1987) Dextran sulfate, a potent anti-HIV agent in vitro having synergism with zidovudine. Lancet, 1, 1379.
32. Watton, J., Longstaff, C., Lane, D.A. and Barrowcliffe, T.W. (1993) Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III. Biochemistry, 32, 7286-7293.
33. Wilson, A.P. and Rider, C.C. (1991) Murine T lymphocytes and T-lymphoma cells produce chondroitin sulfate and heparan sulfate proteoglycans and free heparan sulfate glycosaminoglycans. Immunology, 72, 27-33.